Skip to main content
Have a personal or library account? Click to login
Prolactinoma - which patients react favorably to cabergoline medication? Cover

Prolactinoma - which patients react favorably to cabergoline medication?

Endocrine Regulations
Volume 56 (2022): Issue 4 (October 2022)
By: Savas Karatas,  Yalcin Hacioglu and  Taskin Rakicioglu  
Open Access
|Oct 2022
Authors

Authors

Savas Karatas

drsavaskaratas@yahoo.com

Endocrinology and Metabolism Department, Istanbul Research and Education Hospital, Istanbul, Turkey

Yalcin Hacioglu

Family Medicine Department, Istanbul Research and Education Hospital, Istanbul, Turkey

Taskin Rakicioglu

Radiology Department, Istanbul Research and Education Hospital, Istanbul, Turkey
DOI: https://doi.org/10.2478/enr-2022-0030 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 279 - 283
Published on: Oct 20, 2022
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
prolactinoma,
pituitary,
endocrinology
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2022 Savas Karatas, Yalcin Hacioglu, Taskin Rakicioglu, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 56 (2022): Issue 4 (October 2022)
Previous article
Next article